Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Astellas
Astellas
FDA panel backs Astellas drug for invasive fungal infections
Yahoo/Reuters
Thu, 01/22/15 - 02:34 pm
FDA
Astellas
advisory panels
Isavuconazonium
fungal infections
Astellas' Isavuconazonium Should Pass Ad Comm Meeting For 2 Indications
Seeking Alpha
Wed, 01/21/15 - 12:00 pm
Astellas
Isavuconazonium
FDA
advisory panels
aspergillosis
mucormycosis
Astellas adds to deal spree with expanded $675M-plus Cytokinetics pact
Fierce Biotech
Tue, 12/23/14 - 10:01 am
Astellas
Cytokinetics
CK-2127107
spinal muscular atrophy
Data Presented From Phase 2 Study of Enzalutamide in Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer
Yahoo/MarketWired
Sat, 12/13/14 - 11:26 am
Enzalutamide
Medivation
Astellas
breast cancer
J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III
Fierce Biotech
Tue, 12/2/14 - 09:25 am
JNJ
Astellas
rheumatoid arthritis
ASP015K
JAK inhibitors
3 Biotech Stocks Growing Faster Than Gilead Sciences Inc.
Motley Fool
Mon, 10/27/14 - 08:10 am
biotech
Gilead Sciences
Medivation
Astellas
Celgene
Biogen Idec
Astellas dives into gene therapy with a Harvard expert in tow
Fierce Biotech
Tue, 10/14/14 - 09:23 pm
Astellas
gene therapy
Retinitis pigmentosa
J&J Likely To Report Drop In Zytiga Sales On Xtandi‘s Entry In Prostate Cancer Market
Bidness Etc.
Mon, 09/22/14 - 09:56 am
Zytiga
Xtandi
JNJ
prostate cancer
Medivation
Astellas
Xtandi field force to increase by 50% for market-share battle with Zytiga
Fierce Pharma Marketing
Mon, 09/15/14 - 07:30 pm
Xtandi
Medivation
Astellas
hirings
JNJ
Zytiga
Astellas files new drug for life-threatening infections
Pharmaphorum
Mon, 09/8/14 - 08:19 am
Astellas
isavuconazole
antifungals
Astellas Seeks FDA Nod for Fungal Infection Treatment
Yahoo/Zacks.com
Thu, 07/10/14 - 05:50 pm
Astellas
FDA
fungal infections
isavuconazole
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer
Yahoo/BusinessWire
Sun, 06/1/14 - 11:40 am
Enzalutamide
prostate cancer
metastatic prostate cancer
Xtandi
Astellas
Cytokinetics initiates multiple dose Phase I clinical trial of CK-2127107
The Fly on the Wall
Thu, 03/27/14 - 08:18 am
Cytokinetics
CK-2127107
Astellas
Aveo, Astellas end pact to develop cancer drug Tivozanib
Yahoo/Reuters
Fri, 02/14/14 - 11:57 am
Aveo
Astellas
tivozanib
colon cancer
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
AbbVie
Enanta Pharmaceuticals
ABT-450
hepatitis C
Medivation
Xtandi
prostate cancer
Astellas
Geron
imetelstat
PSMA-ADC
Progenics Pharmaceuticals
Idenix
Aveo Oncology to end breast cancer study due to low enrollment
Yahoo/Reuters
Thu, 01/30/14 - 10:07 am
Aveo Oncology
Astellas
tivozanib
breast cancer
clinical trials
Medivation Inc. and Astellas Up the Ante against Johnson & Johnson
Motley Fool
Wed, 01/29/14 - 05:46 pm
Medivation
Astellas
JNJ
Zytiga
Xtandi
prostate cancer
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
JNJ
Medivation
prostatce cancer
Astellas
Dendreon
Sanofi
Zytiga
Xtandi
Provenge
FDA warns of heart risks with Astellas' Lexiscan and Adenoscan
Reuters
Wed, 11/20/13 - 11:14 am
FDA
Astellas
Lexiscan
Adenoscan
Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha
Mon, 11/18/13 - 08:19 am
JNJ
Medivation
prostate cancer
Xtandi
Astellas
Zytiga
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »